Were you looking for more information about Ilaris? Ilara is a common misspelling of Ilaris.
Available by prescription only, Ilaris® (canakinumab) is a medication approved for people who have certain rare genetic disorders that cause inflammation throughout the body. Specifically, this drug is approved for treating a group of conditions called cryopyrin-associated periodic syndromes (CAPS). It is also approved for systemic juvenile idiopathic arthritis (SJIA).
Ilaris is given as an injection just under the skin (subcutaneously) once every eight weeks for CAPS or every four weeks for SJIA. Some people who receive this drug will experience side effects, such as headaches, diarrhea, or nausea.
(Click Ilaris for more information on what this medication is used for, how it works, and what your healthcare provider needs to know before starting treatment. You can also click any of the links in the box to the right for specific information.)